mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.03 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.03 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.03 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.03 |